BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18166147)

  • 1. Ligand-independent pathway that controls stability of interferon alpha receptor.
    Liu J; Plotnikov A; Banerjee A; Suresh Kumar KG; Ragimbeau J; Marijanovic Z; Baker DP; Pellegrini S; Fuchs SY
    Biochem Biophys Res Commun; 2008 Mar; 367(2):388-93. PubMed ID: 18166147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TYK2 activity promotes ligand-induced IFNAR1 proteolysis.
    Marijanovic Z; Ragimbeau J; Kumar KG; Fuchs SY; Pellegrini S
    Biochem J; 2006 Jul; 397(1):31-8. PubMed ID: 16551269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducible priming phosphorylation promotes ligand-independent degradation of the IFNAR1 chain of type I interferon receptor.
    Bhattacharya S; HuangFu WC; Liu J; Veeranki S; Baker DP; Koumenis C; Diehl JA; Fuchs SY
    J Biol Chem; 2010 Jan; 285(4):2318-25. PubMed ID: 19948722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation and specific ubiquitin acceptor sites are required for ubiquitination and degradation of the IFNAR1 subunit of type I interferon receptor.
    Kumar KG; Krolewski JJ; Fuchs SY
    J Biol Chem; 2004 Nov; 279(45):46614-20. PubMed ID: 15337770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand-stimulated downregulation of the alpha interferon receptor: role of protein kinase D2.
    Zheng H; Qian J; Varghese B; Baker DP; Fuchs S
    Mol Cell Biol; 2011 Feb; 31(4):710-20. PubMed ID: 21173164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of p38 protein kinase in the ligand-independent ubiquitination and down-regulation of the IFNAR1 chain of type I interferon receptor.
    Bhattacharya S; Qian J; Tzimas C; Baker DP; Koumenis C; Diehl JA; Fuchs SY
    J Biol Chem; 2011 Jun; 286(25):22069-76. PubMed ID: 21540188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basal ubiquitin-independent internalization of interferon alpha receptor is prevented by Tyk2-mediated masking of a linear endocytic motif.
    Kumar KG; Varghese B; Banerjee A; Baker DP; Constantinescu SN; Pellegrini S; Fuchs SY
    J Biol Chem; 2008 Jul; 283(27):18566-72. PubMed ID: 18474601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SCF(HOS) ubiquitin ligase mediates the ligand-induced down-regulation of the interferon-alpha receptor.
    Kumar KG; Tang W; Ravindranath AK; Clark WA; Croze E; Fuchs SY
    EMBO J; 2003 Oct; 22(20):5480-90. PubMed ID: 14532120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chaperone-Mediated Autophagy Targets IFNAR1 for Lysosomal Degradation in Free Fatty Acid Treated HCV Cell Culture.
    Kurt R; Chandra PK; Aboulnasr F; Panigrahi R; Ferraris P; Aydin Y; Reiss K; Wu T; Balart LA; Dash S
    PLoS One; 2015; 10(5):e0125962. PubMed ID: 25961570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammalian casein kinase 1alpha and its leishmanial ortholog regulate stability of IFNAR1 and type I interferon signaling.
    Liu J; Carvalho LP; Bhattacharya S; Carbone CJ; Kumar KG; Leu NA; Yau PM; Donald RG; Weiss MJ; Baker DP; McLaughlin KJ; Scott P; Fuchs SY
    Mol Cell Biol; 2009 Dec; 29(24):6401-12. PubMed ID: 19805514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressor of cytokine signaling (SOCS) 1 inhibits type I interferon (IFN) signaling via the interferon alpha receptor (IFNAR1)-associated tyrosine kinase Tyk2.
    Piganis RA; De Weerd NA; Gould JA; Schindler CW; Mansell A; Nicholson SE; Hertzog PJ
    J Biol Chem; 2011 Sep; 286(39):33811-8. PubMed ID: 21757742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-specific ubiquitination exposes a linear motif to promote interferon-alpha receptor endocytosis.
    Kumar KG; Barriere H; Carbone CJ; Liu J; Swaminathan G; Xu P; Li Y; Baker DP; Peng J; Lukacs GL; Fuchs SY
    J Cell Biol; 2007 Dec; 179(5):935-50. PubMed ID: 18056411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organ-specific and differential requirement of TYK2 and IFNAR1 for LPS-induced iNOS expression in vivo.
    Painz R; Walter I; Kolbe T; Rigler D; Vogl C; Steinborn R; Rülicke T; Helmreich M; Karaghiosoff M; Müller M
    Immunobiology; 2007; 212(9-10):863-75. PubMed ID: 18086385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The amino-terminal region of Tyk2 sustains the level of interferon alpha receptor 1, a component of the interferon alpha/beta receptor.
    Gauzzi MC; Barbieri G; Richter MF; Uzé G; Ling L; Fellous M; Pellegrini S
    Proc Natl Acad Sci U S A; 1997 Oct; 94(22):11839-44. PubMed ID: 9342324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A role for Janus kinases in crosstalk between ErbB3 and the interferon-alpha signaling complex in myeloma cells.
    Walters DK; Jelinek DF
    Oncogene; 2004 Feb; 23(6):1197-205. PubMed ID: 14647450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein tyrosine phosphatase 1B is a key regulator of IFNAR1 endocytosis and a target for antiviral therapies.
    Carbone CJ; Zheng H; Bhattacharya S; Lewis JR; Reiter AM; Henthorn P; Zhang ZY; Baker DP; Ukkiramapandian R; Bence KK; Fuchs SY
    Proc Natl Acad Sci U S A; 2012 Nov; 109(47):19226-31. PubMed ID: 23129613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional cartography of the ectodomain of the type I interferon receptor subunit ifnar1.
    Lamken P; Gavutis M; Peters I; Van der Heyden J; Uzé G; Piehler J
    J Mol Biol; 2005 Jul; 350(3):476-88. PubMed ID: 15946680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antiviral action of interferon is potentiated by removal of the conserved IRTAM domain of the IFNAR1 chain of the interferon alpha/beta receptor: effects on JAK-STAT activation and receptor down-regulation.
    Basu L; Yang CH; Murti A; Garcia JV; Croze E; Constantinescu SN; Mullersman JE; Pfeffer LM
    Virology; 1998 Mar; 242(1):14-21. PubMed ID: 9501047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor-induced elimination of the type 1 interferon receptor is required for efficient angiogenesis.
    Zheng H; Qian J; Carbone CJ; Leu NA; Baker DP; Fuchs SY
    Blood; 2011 Oct; 118(14):4003-6. PubMed ID: 21832278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRIM10 binds to IFN-α/β receptor 1 to negatively regulate type I IFN signal transduction.
    Guo M; Cao W; Chen S; Tian R; Wang L; Liu Q; Zhang L; Wang Z; Zhao M; Lu Q; Zhu H
    Eur J Immunol; 2021 Jul; 51(7):1762-1773. PubMed ID: 33811647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.